CT 3 times, bone scintigraphy 3 times, laboratory examination 4 times

2 trials

Sponsors

Nagoya University Graduate School and School of Medicine

Conditions

Patients with bone metastases newly treated by denosumabPatients with bone metastases newly treated by zoledronic acid

Unknown Phase

Research for biomarkers to predict the effectiveness of zoledronic acid in metastatic bone tumors

Active, not recruitingJPRN-UMIN000018556

Nagoya University Graduate School and School of MedicinePatients with bone metastases newly treated by zoledronic acid

Start: 2013-02-08Target: 60Updated: 2026-06-29

Research for biomarkers to predict the effectiveness of denosumab in metastatic bone tumors

Active, not recruitingJPRN-UMIN000019700

Nagoya University Graduate School and School of MedicinePatients with bone metastases newly treated by denosumab

Start: 2013-02-08Target: 60Updated: 2026-06-29